Familial Prostate Cancer Overview

Save information for later
Sign Up

Learn About Familial Prostate Cancer

View Main Condition: Prostate Cancer

What is the definition of Familial Prostate Cancer?
Familial prostate cancer is a cluster of prostate cancer within a family. Most cases of prostate cancer occur sporadically in people with no family history of the condition. However, approximately 5% to 10% of prostate cancer cases are believed to be primarily caused by a genetic predisposition to the condition. In many families, the underlying genetic cause is unknown; however, some of these cases are caused by changes in the BRCA1, BRCA2, HOXB13, or several other genes. Other cases are likely due to a combination of gene(s) and other shared factors such as environment and lifestyle. High-risk cancer screening at an earlier age is typically recommended in men who have an increased risk for prostate cancer based on personal and/or family histories.
What are the alternative names for Familial Prostate Cancer?
  • Familial prostate cancer
  • Hereditary prostate cancer
  • Prostate cancer, familial
  • Prostate cancer, hereditary
Who are the top Familial Prostate Cancer Local Doctors?
Elite in Familial Prostate Cancer
Dr. Scott E. Eggener
Urology
Elite in Familial Prostate Cancer
Dr. Scott E. Eggener
Urology

The University Of Chicago

5841 S Maryland Ave, 
Chicago, IL 
773-702-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Eggener is an Urologist in Chicago, Illinois. Dr. Eggener is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Eggener is currently accepting new patients.

Elite in Familial Prostate Cancer
Dr. Tanya B. Dorff
Oncology | Hematology Oncology
Elite in Familial Prostate Cancer
Dr. Tanya B. Dorff
Oncology | Hematology Oncology

City Of Hope Medical Foundation

209 Fair Oaks Ave, 
South Pasadena, CA 
626-396-2900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tanya Dorff is an Oncologist and a Hematologist Oncology provider in South Pasadena, California. Dr. Dorff is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. Her top areas of expertise are Prostate Cancer, Penile Cancer, Familial Prostate Cancer, Prostatectomy, and Penectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Familial Prostate Cancer
Dr. Russell Z. Szmulewitz
Hematology Oncology | Hematology | Oncology
Elite in Familial Prostate Cancer
Dr. Russell Z. Szmulewitz
Hematology Oncology | Hematology | Oncology

The University Of Chicago

1101 S Canal St, Suite 201, 
Chicago, IL 
877-336-5667
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Russell Szmulewitz is a Hematologist Oncology specialist and a Hematologist in Chicago, Illinois. Dr. Szmulewitz is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Orchiectomy. Dr. Szmulewitz is currently accepting new patients.

View All Doctors
What are the latest Familial Prostate Cancer Clinical Trials?
A Multi-center Investigation of Family Health, Needs, Perceived Support, Self-efficacy and Quality of Life During the Cancer Trajectory: A Longitudinal Mixed Methods Study Among Danish Cancer Patients and Their Caregivers
A Multi-center Investigation of Family Health, Needs, Perceived Support, Self-efficacy and Quality of Life During the Cancer Trajectory: A Longitudinal Mixed Methods Study Among Danish Cancer Patients and Their Caregivers
Enrollment Status: Recruiting
Publish Date: October 06, 2025
Intervention Type: Other

Summary: The current healthcare system is unable to identify burdened and vulnerable families affected by cancer, partly due to a lack of knowledge of how cancer affects family health during treatment and survivorship. Recent reviews have documented a general lack of cancer studies including both the patient and the family, and a particular deficiency in studies including more than the spouse. The principa...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Who is this study for: Adult patients with prostate cancer
Enrollment Status: Recruiting
Publish Date: September 30, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Abiraterone acetate, Prednisone
Study Phase: Phase 2

Summary: The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary analysis or the study specified evaluation period.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center